Sangeeta Bhatia

Sangeeta is the John J. and Dorothy Wilson Professor of Engineering at MIT, Director of the Marble Center for Cancer Nanomedicine, and HHMI Investigator. She also holds appointments at the Koch Institute for Integrative Cancer Research, the Broad Institute, the Wyss Institute, and Brigham & Women’s Hospital.

Trained as both a physician and engineer at Brown, MIT, Harvard, and MGH, Sangeeta’s laboratory leverages miniaturization tools from the computer industry for medical innovation with applications in liver disease, oncology, and infectious diseases. She and her over 150 trainees have contributed to more than 50 issued or pending patents, launched multiple biotechnology companies, and published more than 200 peer-reviewed papers. Bhatia was the 25th person in history to be an elected member of all three US National Academies: NAS, NAM, and NAE. She has been honored with the Lemelson-MIT Prize, the Heinz Medal, and the Othmer Gold Medal for groundbreaking inventions and advocacy for women in STEM fields. She has presented her vision for the application of engineering solutions to solve medical problems on international stages such as the World Economic Forum, TED, the Gates Grand Challenges, and the Biden Cancer Moonshot. She currently serves as a Trustee at Brown University and Director at Vertex Pharmaceuticals.